Upcoming free CE: Understanding Blood-Based Biomarkers (BBMs) for Alzheimer’s Disease

Join us for an in-depth look at the science behind BBMs, and their integration into the AT(N) diagnostic framework. Attendees are eligible for 1 CE credit hour. This free event is sponsored by Beckman Coulter.

LABline

Feb. 6, 2026

Date: February 11, 2026, at 12:00 PM CST
Credits: 1 CE
Presenter: Dr. James Galvin, MD, MPH
Sponsor: Beckman Coulter
Cost: Free

Blood-based biomarkers (BBMs) are rapidly emerging as a practical and minimally invasive tool for improving Alzheimer’s disease (AD) diagnosis and patient care. This webinar will provide laboratory professionals with an in-depth look at the science behind BBMs, including key markers such as p-tau217, Aβ42/40, neurofilament light (NfL), and GFAP, and their integration into the AT(N) diagnostic framework. We will examine assay performance, analytical considerations, and the advantages and limitations of plasma-based testing compared to CSF and imaging modalities. Attendees will gain actionable insights into current and future applications of BBMs in clinical workflows, regulatory status, and how these innovations can support accurate, cost-effective testing in diverse laboratory settings.